Back to results
US 2006/0052387 A1Published application
Organic compounds
OwnerClay Marshinventor
Life of this patent
Estimating the term…
Abstract
4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2ylamino)phenyl]benzamide of the formula (I): or a pharmaceutically acceptable salt thereof for the treatment of inflammation.
Claims21
A method for reducing inflammation in a subject, the method comprising administering an anti-inflammatory effective amount of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide of Compound I
- or a pharmaceutically acceptable salt thereof to the subject in need of such treatment.
13-27. (canceled)
Dependencies are inferred from the claim text.